Close Menu
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
What's Hot

Isomorphic Labs raises $5 billion to advance clinical trials of new drug candidates

November 17, 2026

President Trump: ‘We take the Iranian dirty bomb report very seriously’

November 17, 2026

Anthropic’s IPO price is likely to exceed the current $70 to $78, sources told CNBC.

November 17, 2026
Facebook X (Twitter) Instagram
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Facebook X (Twitter) Instagram
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Home » Isomorphic Labs raises $5 billion to advance clinical trials of new drug candidates
AI

Isomorphic Labs raises $5 billion to advance clinical trials of new drug candidates

Editor-In-ChiefBy Editor-In-ChiefNovember 17, 2026No Comments2 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
Follow Us
Google News Flipboard
Share
Facebook Twitter LinkedIn Pinterest Email


Isomorphic Labs, the AI ​​drug discovery platform spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round to move new drug candidates into clinical trials.

The funding was co-led by Greenoaks and Sequoia Capital, with participation from new investor Andreessen Horowitz and other investors. The company’s existing backers, including Alphabet’s venture arm GV and Capita G, Thrive Capital, MGX, Temasek and the UK Sovereign AI Fund, all also invested.

Isomorphic Labs is building an AI drug design engine that uses numerous simulation AI models that explore various areas of chemistry to aid the company’s drug design. The company, whose research is based on DeepMind’s breakthrough AlphaFold protein folding AI model, said its program has produced “positive preclinical results” in oncology and immunology. The institute has contracts with major pharmaceutical companies including Eli Lilly, Novartis, and Johnson & Johnson.

The new funding, which follows a $2.1 billion Series B round in May, will be used to continue developing the drug design engine and expand into more types of drugs.

The Series C is Isomorphic’s first funding since Demis Hassabis, Isomorphic’s founder and CEO, stepped down as DeepMind’s executive director to focus on drug discovery and became DeepMind’s chairman. Hassabis and John Jumper, then head of DeepMind, won the Nobel Prize in Chemistry for their lab’s work on alphafold, a system that predicts the three-dimensional structure of proteins based solely on gene sequence.

Isomorphic did not disclose its new valuation. Bloomberg reported earlier this month that the institute was considering raising capital at a valuation of $50 billion.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Editor-In-Chief
  • Website

Related Posts

Voyage Labs raises $12 million for specialized AI travel assistant

November 17, 2026

Daydream’s new AI agent can act as your personal stylist and even shop for you

November 17, 2026

Jensen Huang says he would be ‘honored’ if allowed to return as NVIDIA CEO

November 17, 2026
Add A Comment

Comments are closed.

News

President Trump announces critical minerals agreement at Quad meeting in Manila | Political News

By Editor-In-ChiefNovember 17, 2026

President Trump said the deal would prevent “coercion by a single foreign supplier.”US President Donald…

After 26 years of historic setbacks, US officially loses measles-free status | Health News

November 17, 2026

CAIR defends civil rights movement against President Trump’s ‘slander’ | Donald Trump News

November 17, 2026
Top Trending

Isomorphic Labs raises $5 billion to advance clinical trials of new drug candidates

By Editor-In-ChiefNovember 17, 2026

Isomorphic Labs, the AI ​​drug discovery platform spun out of Google’s DeepMind…

Voyage Labs raises $12 million for specialized AI travel assistant

By Editor-In-ChiefNovember 17, 2026

Travel planning is a favorite demonstration for personal AI assistants. You can…

Daydream’s new AI agent can act as your personal stylist and even shop for you

By Editor-In-ChiefNovember 17, 2026

Would an AI agent act as your personal stylist? That’s what e-commerce…

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Welcome to WhistleBuzz.com (“we,” “our,” or “us”). Your privacy is important to us. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website https://whistlebuzz.com/ (the “Site”). Please read this policy carefully to understand our views and practices regarding your personal data and how we will treat it.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Facebook X (Twitter) Instagram Pinterest
  • Home
  • Advertise With Us
  • Contact US
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
  • About US
© 2026 whistlebuzz. Designed by whistlebuzz.

Type above and press Enter to search. Press Esc to cancel.